These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 5369593)
1. [Clinico-electrocardiographic aspects of the use of cardiac glycosides in children]. Reznik BIa; Shidogub EN Pediatriia; 1969 Nov; 48(11):41-3. PubMed ID: 5369593 [No Abstract] [Full Text] [Related]
2. [Cliical aspects of cardiocinetic therapy with a new cardioactive glucoside: acetyldigoxin]. Malaguti P Minerva Cardioangiol; 1968 Mar; 16(3):225-30. PubMed ID: 5740756 [No Abstract] [Full Text] [Related]
3. [Diuretic interaction with cardiac glycosides in mitral defect patients]. Bakaev VV; Arkhipova GF; Kelin EP Vrach Delo; 1979 Nov; (11):25-7. PubMed ID: 524810 [No Abstract] [Full Text] [Related]
5. [Drug-hormonal therapy of children suffering from rheumatism with second-third stage circulatory insufficiency]. Kovaleva EV; Shishova EM; Isakova AV Pediatriia; 1966 Nov; 45(11):50-3. PubMed ID: 6002740 [No Abstract] [Full Text] [Related]
6. [Cardiac glycoside treatment of children with rheumatic fever and circulatory insufficiency]. Borisova TP; Serbin VI Vopr Okhr Materin Det; 1972 Apr; 17(4):7-11. PubMed ID: 5081438 [No Abstract] [Full Text] [Related]
7. [Treatment of circulatory disorders with corglycon in rheumatic children]. Ostropolets' SS Pediatr Akus Ginekol; 1965; 4():22-4. PubMed ID: 5888228 [No Abstract] [Full Text] [Related]
8. [Effect of cardiac glycosides on myocardial contractile function and hemodynamics in a circulatory disorder of children with mitral valve insufficiency]. Serbin VI; Oskolkova MK; Gasanova AS; Ivanov AP; Dvoriakovskiĭ IV Pediatriia; 1981 Mar; (3):22-5. PubMed ID: 7220204 [No Abstract] [Full Text] [Related]
9. [Electroca rdiographic control in clinical use of mean therapeutic doses of cardiac glycosides (strophanthin, corglycon)]. Fan-Tkhi-Ngok-Shiong Ter Arkh; 1974; 46(6):83-9. PubMed ID: 4473844 [No Abstract] [Full Text] [Related]
10. [Use of myocardial glycosides in children with congenital heart defects]. Sidel'nikov VM; Son'kin VM Pediatr Akus Ginekol; 1970; 4():17-9. PubMed ID: 5504818 [No Abstract] [Full Text] [Related]
11. [Binding of cardiac glycosides by the erythrocytes of patients]. Bakaev VV Farmakol Toksikol; 1986; 49(5):25-7. PubMed ID: 3770168 [TBL] [Abstract][Full Text] [Related]
12. [Dynamics of the potassium and sodium content in the erythocytes and blood plasma in rheumatic heart defects before and after treatment with cardiac glycosides and in combination with biologically active substances]. Masliuk VI; Saluén'ia AI; Smirnova GA; Burmistrova LP; Samgina TS Sov Med; 1979 Jan; (1):57-61. PubMed ID: 424863 [No Abstract] [Full Text] [Related]
13. [Glycoside treatment characteristics in circulatory insufficiency with inflammatory processes in the heart]. Perchikova GE Kardiologiia; 1975 Oct; 15(10):59-61. PubMed ID: 1234915 [No Abstract] [Full Text] [Related]
15. [Remarks on the clinical picture and current therapeutic possibilities in circulatory insufficiency in children]. Maciejewski J; Sapiński A; Stabrowski M Przegl Lek; 1965; 21(12):710-2. PubMed ID: 5861937 [No Abstract] [Full Text] [Related]